Pendal Group LTD Illumina, Inc. Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$181.58 - $368.0 $144,537 - $292,928	-796 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$303.87 - $423.8 $56,823 - $79,250	187 Added 30.71%	796 $278,000
Q4 2021 Jan 18, 2022	SELL	$347.28 - $421.83 $3,125 - $3,796	-9 Reduced 1.46%	609 $232,000
Q3 2021 Nov 05, 2021	SELL	$405.61 - $524.84 $34,071 - $44,086	-84 Reduced 11.97%	618 $251,000
Q2 2021 Jul 28, 2021	SELL	$372.84 - $481.5 $5,219 - $6,741	-14 Reduced 1.96%	702 $332,000
Q1 2021 May 24, 2021	BUY	$361.28 - $504.76 $258,676 - $361,408	716 New	716 $275,000
Q1 2021 May 03, 2021	SELL	$361.28 - $504.76 $2.24 Million - $3.13 Million	-6,197 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$292.7 - $370.96 $1.03 Million - $1.3 Million	3,507 Added 130.37%	6,197 $2.29 Million
Q3 2020 Nov 02, 2020	BUY	$268.51 - $400.74 $108,746 - $162,299	405 Added 17.72%	2,690 $831,000
Q2 2020 Aug 07, 2020	SELL	$256.46 - $373.01 $7,950 - $11,563	-31 Reduced 1.34%	2,285 $846,000
Q1 2020 May 04, 2020	BUY	$209.2 - $335.53 $258,362 - $414,379	1,235 Added 114.25%	2,316 $632,000
Q4 2019 Feb 06, 2020	BUY	$288.29 - $335.49 $27,387 - $31,871	95 Added 9.63%	1,081 $358,000
Q3 2019 Nov 12, 2019	BUY	$266.84 - $378.23 $23,748 - $33,662	89 Added 9.92%	986 $299,000
Q2 2019 Aug 01, 2019	SELL	$300.59 - $368.15 $452,989 - $554,802	-1,507 Reduced 62.69%	897 $0
Q1 2019 May 01, 2019	BUY	$272.57 - $321.18 $310,729 - $366,145	1,140 Added 90.19%	2,404 $0
Q4 2018 Jan 30, 2019	SELL	$272.46 - $366.54 $49,042 - $65,977	-180 Reduced 12.47%	1,264 $379,000
Q3 2018 Nov 05, 2018	BUY	$279.04 - $367.06 $402,933 - $530,034	1,444 New	1,444 $0

Others Institutions Holding ILMN

# of Institutions

967

Shares Held

151M

Call Options Held

2.37M

Put Options Held

1.41M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $13.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account